Cargando…

Adherence to Weight‐Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Systemic Lupus Erythematosus and Rheumatoid Arthritis: Results of a Quality Improvement Initiative

OBJECTIVE: Hydroxychloroquine (HCQ) is commonly prescribed for the treatment of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other rheumatic diseases. To limit retinal toxicity, the 2016 American Academy of Ophthalmology (AAO) guidelines recommended limiting the HCQ dose to 5 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skorupa, Tara, Shmerling, Robert H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516102/ https://www.ncbi.nlm.nih.gov/pubmed/34363746 http://dx.doi.org/10.1002/acr2.11320

Ejemplares similares

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
por: da Silva, Juliana Cruz, et al.
Publicado: (2013)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2020)

Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls
por: Krasselt, Marco, et al.
Publicado: (2021)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus
por: Bermas, Bonnie L., et al.
Publicado: (2015)

Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in Brazil
por: Prudente, Luciana Resende, et al.
Publicado: (2016)

Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort
por: Walbi, Ismail A., et al.
Publicado: (2022)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Canadian Pregnancy Outcomes in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Barnabe, Cheryl, et al.
Publicado: (2011)

Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis
por: Heijke, Rebecca, et al.
Publicado: (2021)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
por: Leung, Alexander KC, et al.
Publicado: (2020)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
por: Bermas, Bonnie, et al.
Publicado: (2022)

Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus
por: Orozco, Gisela, et al.
Publicado: (2010)

Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2006)

CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Alaaeddine, Nada, et al.
Publicado: (2012)

Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis
por: Hirose, Sachiko, et al.
Publicado: (2019)

Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?
por: Alunno, Alessia, et al.
Publicado: (2021)

Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus
por: Duarte-Delgado, Nancy P., et al.
Publicado: (2022)

Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications
por: Zhang, Bo, et al.
Publicado: (2021)

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Ammitzbøll, Christian, et al.
Publicado: (2021)

Transition Readiness in Adolescents With Juvenile Idiopathic Arthritis and Childhood‐Onset Systemic Lupus Erythematosus
por: McColl, Jeanine, et al.
Publicado: (2021)

Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose
por: Wakiya, Risa, et al.
Publicado: (2020)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
por: Lee, Jae-Eun, et al.
Publicado: (2023)

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence
por: Blanchet, Benoit, et al.
Publicado: (2020)

Efficacy of Abatacept for Arthritis in Patients with an Overlap Syndrome between Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Ikeda, Kei, et al.
Publicado: (2013)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
por: Olsen, Nancy J., et al.
Publicado: (2016)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
por: Baalbaki, Sima, et al.
Publicado: (2020)

Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)
por: Stojanovich, Ljudmila
Publicado: (2006)

Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus
por: Robinson, W, et al.
Publicado: (2002)

Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and sysemic lupus erythematosus
por: Nagy, György, et al.
Publicado: (2010)

Subpopulations of Regulatory T Cells in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Behcet's Disease
por: Kim, Jae-Ryong, et al.
Publicado: (2012)

Neonatal Lupus erythematosus Following Rheumatoid Arthritis: Case Report and Literature Review
por: Assari, Raheleh, et al.
Publicado: (2014)

Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis
por: Legge, Alexandra, et al.
Publicado: (2017)

Bone mineral density in children with systemic lupus erythematosus and juvenile rheumatoid arthritis
por: Kashef, Sara, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_g25nmb55ti19nvouk3nu9cnks9